Skip to main content

Solifenacin Side Effects

Medically reviewed by Drugs.com. Last updated on Nov 23, 2023.

Applies to solifenacin: oral suspension, oral tablet.

Serious side effects of Solifenacin

Along with its needed effects, solifenacin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking solifenacin:

More common

Less common

Incidence not known

Other side effects of Solifenacin

Some side effects of solifenacin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to solifenacin: oral suspension, oral tablet.

Gastrointestinal

Very common (10% or more): Dry mouth (up to 28%), constipation (up to 13%)

Common (1% to 10%): Nausea, dyspepsia, upper abdominal pain, vomiting

Uncommon (0.1% to 1%): Gastroesophageal reflux disease, dry throat, flatulence, throat irritation, eructation, thirst

Rare (less than 0.1%): Colonic obstruction, fecal impaction

Postmarketing reports: Ileus[Ref]

Respiratory

Common (1% to 10%): Pharyngitis, cough, sinusitis, bronchitis

Uncommon (0.1% to 1%): Nasal dryness

Postmarketing reports: Dysphonia[Ref]

Psychiatric

Common (1% to 10%): Depression

Postmarketing reports: Confusion, hallucinations, delirium, somnolence[Ref]

Ocular

Common (1% to 10%): Blurred vision, dry eyes

Very rare (less than 0.01%): Glaucoma[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection, urinary retention

Uncommon (0.1% to 1%): Cystitis, suprapubic pain, bladder pain, micturition urgency[Ref]

Cardiovascular

Common (1% to 10%): Lower limb edema, hypertension

Uncommon (0.1% to 1%): Syncope, chest tightness, hot flushes

Postmarketing reports: Peripheral edema, QT prolongation, Torsade de Pointes, atrial fibrillation, tachycardia, palpitations, atrial fibrillation[Ref]

Dermatologic

Uncommon (0.1% to 1%): Dry skin

Rare (0.01% to 0.1%): Pruritus, rash

Very rare (less than 0.01%): Erythema multiforme, urticaria, angioedema, exfoliative dermatitis[Ref]

Immunologic

Common (1% to 10%): Influenza[Ref]

Metabolic

Very rare (less than 0.01%): Decreased appetite, hyperkalemia[Ref]

Hypersensitivity

Very rare (less than 0.01%): Hypersensitivity reactions (including angioedema with airway obstruction, rash, pruritus, urticaria, and anaphylactic reaction)[Ref]

Other

Common (1% to 10%): Fatigue[Ref]

Renal

Very rare (less than 0.01%): Renal impairment[Ref]

Hepatic

Postmarketing reports: Abnormal liver function tests, AST (aspartate aminotransferase), ALT (alanine aminotransferase), GGT (gamma-glutamyl transferase)[Ref]

Musculoskeletal

Common (1% to 10%): Arthralgia, back pain

Uncommon (0.1% to 1%): Neck pain

Postmarketing reports: Muscular weakness[Ref]

Nervous system

Common (1% to 10%): Dizziness, insomnia

Uncommon (0.1% to 1%): Dysgeusia

Rare (0.01% to 0.1%): Headache

Postmarketing reports: Headache, tremors[Ref]

References

1. Product Information. VESIcare (solifenacin). GlaxoSmithKline. 2004.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.